Skip to main content

FDA's Tox Center to Use Genedata's Biomarker Software

NEW YORK (GenomeWeb News) - The US Food and Drug Administration’s National Center for Toxicological Research will use Genedata’s biomarker-discovery software, the company said today.
 
The NCTR’s Center for Toxicoinformatics will use the company’s Expressionist software to support the “vast quantities and varied sources of microarray data” used in its voluntary genomics data submission program.
 
The software is used for biomarker research involving transcriptomics, proteomics, and metabolomics data, Genedata said.
 
Genedata’s managing director, Jens Hoefkens, said the agreement will ensure that its customers will be using the same tools as the FDA to identify markers.
 
Financial terms of the agreement were not released.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.